Biomedical Engineering Reference
In-Depth Information
Lei, B., Chen, X. F., Wang, Y. J., and Zhao, N.,
2009. Synthesis and
in vitro
bioactivity of
novel mesoporous hollow bioactive glass microspheres.
Mater Lett
63: 1719-21.
Lei, B., Chen, X. F., Wang, Y. J., Zhao, N., Du, C.,
et al., 2009. Acetic acid derived meso-
porous bioactive glasses with an enhanced
in vitro
bioactivity.
J Non-Cryst Solid
355: 2583-7.
Leonova, E., Izquierdo-Barba, I., Arcos, D., et al., 2008. Multinuclear solid-state NMR
studies of ordered mesoporous bioactive glasses.
J Phys Chem C
112: 5552-62.
Li, R., Clark, A. E., and Hench, L. L., 1991. An investigation of bioactive glass powders
by sol-gel processing.
J Appl Biomater
2: 231-9.
Li, X., Shi, J., Dong, X.,
et al., 2008. A mesoporous bioactive glass/polycaprolactone
composite scaffold and its bioactivity behavior.
J Biomed Mater Res A
84: 84-91.
Li, X., Wang, X. P., Chen, H. R.,
et al., 2007. Hierarchically porous bioactive glass scaf-
folds synthesized with a PUF and P123 cotemplated approach.
Chem Mater
19:
4322-6.
Li, X., Wang, X. P., He, D. N.,
et al., 2008. Synthesis and characterization of meso-
porous CaO-MO-SiO2-P2O5 (M = Mg, Zn, Cu) bioactive glasses/composites.
J
Mater Chem
18: 4103-9.
Li, X., Wang, X. P., Hua, Z. L.,
et al., 2008. One-pot synthesis of magnetic and mesopo-
rous bioactive glass composites and their sustained drug release property.
Acta
Mater
56: 3260-5.
Li, X., Wang, X., Zhang, L.,
et al., 2009. MBG/PLGA composite microspheres with
prolonged drug release.
J Biomed Mater Res B Appl Biomater
89: 148-54.
Lin, H. M., Wang, W. K., Hsiung, P. A.,
et al., 2010. Light-sensitive intelligent drug
delivery systems of coumarin-modified mesoporous bioactive glass.
Acta
Biomater
6: 3256-63.
Lin, J., Fan, Y., Yang, P. P.,
et al., 2009. Luminescent and mesoporous europium-doped
bioactive glasses (MBG) as a drug carrier.
J Phys Chem C
113: 7826-30.
Lopez-Noriega, A., Arcos, D., and Vallet-Regi, M., 2010. Functionalizing mesopo-
rous bioglasses for long-term anti-osteoporotic drug delivery.
Chem Eur J
16:
10879-86.
Lopez-Noriega, A., Arcos, D., Izquierdo-Barb, I.,
et al., 2006. Ordered mesoporous
bioactive glasses for bone tissue regeneration.
Chem Mater
18: 3137-44.
Manzanoab, M., and Vallet-Regi, M., 2010. New developments in ordered mesopo-
rous materials for drug delivery.
J Mater Chem
20: 5593-5604.
Miranda, P., Pajares, A., Saiz, E.,
et al., 2008. Mechanical properties of calcium phos-
phate scaffolds fabricated by robocasting.
J Biomed Mater Res A
85: 218-27.
Miranda, P., Saiz, E., Gryn, K.,
et al., 2006. Sintering and robocasting of beta-trical-
cium phosphate scaffolds for orthopaedic applications.
Acta Biomater
2: 457-66.
Misra, S. K., Ansari, T., Mohn, D., et al., 2010. Effect of nanoparticulate bioactive glass
particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) com-
posites.
J R Soc Interface
7: 453-65.
Mourino, V., and Boccaccini, A. R., 2010. Bone tissue engineering therapeutics:
Controlled drug delivery in three-dimensional scaffolds.
J R Soc Interface
7:
209-27.
Salinas, A. J., Shruti, S., Malavasi, G.,
et al., 2011. Substitutions of cerium, gallium and
zinc in ordered mesoporous bioactive glasses.
Acta Biomater
7: 3452-8.
Valerio, P., Pereira, M. M., Goes, A. M.,
et al., 2004. The effect of ionic products from
bioactive glass dissolution on osteoblast proliferation and collagen production.
Biomaterials
25: 2941-8.
Search WWH ::
Custom Search